SEC 13F Intelligence

1492 Capital Management LLC / AXSM

1492 Capital Management LLC’s Axsome Therapeutics Inc. Position

Does 1492 Capital Management LLC own Axsome Therapeutics Inc. (AXSM)? Yes — 18.6K shares worth $3M (+1.20% of its 13F portfolio) as of Q1 2026, up from 18.1K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
18.6K
% of Portfolio
+1.20%
Quarters Held
5
currently held

Position History AXSM

Reported value by quarter
Q4 ’24: $963,285Q4 ’24Q2 ’25: $1MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202618.6K$3M+1.20%
Q4 202518.1K$3M+1.26%
Q3 202518.1K$2M+0.89%
Q2 202511.8K$1M+0.57%
Q4 202411.4K$963,285+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 1492 Capital Management LLC’s full portfolio or all institutional holders of AXSM.